What is Infectious Disease Testing Market?
Infectious disease is caused by bacteria, viruses, and others and has a huge impact on the healthcare systems of the countries. Infectious disease testing is the process of identification of causative organisms for the primary diagnosis of diseases. Infectious diseases testing samples include blood, urine, and other bodily fluids. Growing demand for rapid diagnostic techniques over the current techniques owing to the long turnaround time and supportive government funding along with the growing awareness for early detection using specific diagnostic tests is the major factor driving the growth of the global infectious disease testing market.
The market study is being classified by Type (Assays, Kits, & Reagents, Instruments and Services and Software) and major geographies with country level break-up.
Abbott Laboratories (United States), Becton, Dickinson, and Company (United States), Biomérieux SA (France), Bio-Rad Laboratories (United States), Danaher Corporation (United States), Diasorin (Italy), Luminex (United States), Meridian Bioscience (United States), Quidel (United States) and Siemens AG (Germany) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Roche Diagnostics (Switzerland) and Thermo Fisher Scientific (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Infectious Disease Testing market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Infectious Disease Testing market by Type, Application and Region.
On the basis of geography, the market of Infectious Disease Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Prevalence of Infectious Diseases across the Globe
- Growing Inclination for Centralized Laboratories to Decentralized Point-of-Care Testing
- Rising in Funding for Research on Infectious Disease Diagnostics
- Growing Demand for Rapid Diagnostic Techniques
- Inadequate Reimbursements Hindering the Growth of the Market
- Advances in Genomics and Proteomics
- Growing Awareness about Personalized Medicine
- Rising Healthcare Costs Limiting the use of Novel Diagnostic Techniques
On 3rd April 2020, Siemens Healthineers has announced the availability of its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease.
Key Target AudienceInfectious Disease Testing Providers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase